Artemis Medicare Services Limited has informed the Exchange about change in Senior Management
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services reported audited FY25 results with revenue from operations of Rs 913.26 crore (up 8% from Rs 845.23 crore in FY24) and standalone net profit of Rs 83.46 crore (up nearly 70% from Rs 49.15 crore in FY24). Q4 FY25 revenue grew to Rs 234.80 crore with net profit of Rs 23.20 crore versus Rs 13.92 crore in Q4 FY24, with full-year EPS at Rs 5.42 versus Rs 3.62. The Board recommended a final dividend of Re. 0.45 per share (45%) subject to shareholder approval. On the board front, Mr. Sunam Sarkar was appointed as an Additional Non-Executive, Non-Independent Director, Dr. Nirmal Kumar Ganguly resigned as Non-Executive, Non-Independent Director citing personal reasons, and Independent Director Ms. Deepa Gopalan Wadhwa's term ends on May 21, 2025. The Group CIO Mr. Pradeep Kumar Saha was designated as part of senior management, and M/s DMK Associates was appointed as Secretarial Auditor for five years from FY26 to FY30.
Strong profit growth of nearly 70% YoY is the most positive takeaway for shareholders, though the 45% final dividend is modest. The board changes appear routine with one new director joining, one resignation for personal reasons, and one independent director completing her term — nothing flagged as governance concern.